Hideaki Miyake

16PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsNutrigenomics and personalised nutritionNeural networks
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 12, 2026
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study.

Atsushi Mizokami, Rikiya Matsumoto, Hideaki Miyake

|Dec 17, 2024
Utility of Machine Learning Models to Predict Lymph Node Metastasis of Japanese Localized Prostate Cancer.

Hideto Ueki, Tomoaki Terakawa, Takuto Hara

|Feb 06, 2024
Prevalence and management of proteinuria associated with vascular endothelial growth factor receptor-targeted tyrosine kinase inhibitor treatment in advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer.

Taigo Kato, Ryuichi Mizuno, Hideaki Miyake

|Dec 07, 2023
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma.

Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara

|Nov 25, 2023
The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center Study.

Taku Naiki, Kiyoshi Takahara, Hiromitsu Watanabe

|May 26, 2023
Robot-assisted adrenalectomy using a hinotori surgical robot system: Report of first series of six cases.

Daisuke Motoyama, Yuto Matsushita, Hiromitsu Watanabe

Pageof 3

Frequent Collaborators

3 joint publications

Atsushi Otsuka

3 joint publications

Daisuke Motoyama

3 joint publications

Yuto Matsushita

2 joint publications

Takahisa Suzuki